Home › Neuroblastoma › Texas › Fort Worth
Neuroblastoma clinical trials in Fort Worth, TX
4 studies for Neuroblastoma are looking for participants at sites in and around Fort Worth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Cook Children's Medical Center, Fort Worth
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Cook Children's Medical Center, Fort Worth
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
RecruitingPhase 2
- Cook Children's Medical Center, Fort Worth
Neuroblastoma Biology Study
RecruitingObservational study
- Cook Children's Medical Center - Fort Worth, Fort Worth
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- New York City, NY12 studies
- Washington, DC11 studies
- Dallas, TX10 studies
- Cincinnati, OH9 studies
- St. Louis, MO9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Aurora, CO9 studies
- Hartford, CT8 studies
- Birmingham, AL8 studies
- Harrisburg, PA8 studies
Other studies in Fort Worth
- Non-Small Cell Lung Cancer20 studies
- Ovarian Cancer19 studies
- Breast Cancer14 studies
- Endometrial Cancer11 studies
- Cancer (all types)10 studies
- Prostate Cancer10 studies
- Heart Failure8 studies
- Metastatic Cancer8 studies
- Ulcerative Colitis8 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Triple-Negative Breast Cancer7 studies
- Obesity7 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.